The Accumulation of Psoralen Contributes to Its Hepatotoxicity Revealed by Pharmacokinetic and Toxicokinetic Study after Repeated Administration.
ACS omega
Yang L, Yu YL, Cheng LY, Zhang PY, Zhang Y, Zhou K.
Publication Overview
Key findings, Countstar context, and access to the original paper.
2020
Cell Counting & Viability
No items found.
Key Finding
A 20 and 40 μM dose of psoralen did not induced cell death in the 1st day but significantly decreased the cell viability at the 3rd and 4th day of repeated administration, respectively.
Countstar Connection
For the study's cell samples, Countstar (model not specified) provided cell measurements during growth assessment in the 2020 ACS omega study.
